Literature DB >> 14740949

Biologic properties of dengue viruses following serial passage in primary dog kidney cells: studies at the University of Hawaii.

Scott B Halstead1, Nyven J Marchette.   

Abstract

Serial passage at low dilution of seven different wild-type dengue (DEN) viruses into primary dog kidney (PDK) cell cultures placed selective pressure that resulted in the following changes from parental phenotype: smaller plaques in LLC-MK2 cells, absent plaque formation in green monkey kidney cells, lack of a cytopathic effect in LLC-MK2 cells, shut-off of virus replication at high temperatures (temperature sensitivity), reduced virulence for rhesus monkeys manifested by reduced or absent viremia and/or absence of a secondary-type antibody response following homotypic challenge, and progressive increase in the mean day of death following intracerebral inoculation of sucking mice. Two DEN-1 strains showed most of these changes by the 15th PDK passage. Only one of two DEN-2 strains studied was carried to the 50th PDK passage at the University of Hawaii. For the latter strain, both the temperature of viral replicative shutoff and mouse neurovirulence were reduced. Three DEN-4 strains showed similar late-passage biologic marker changes. The observations made, although not exhaustive, provide laboratory correlates for virus strains that have shown reduced virulence but retained immunogenicity in humans. Candidate human vaccines have been prepared from five of the studied strains: DEN-1 (16007) at PDK 13, DEN-2 (16681 and S-16803) at PDK 50 or above, and DEN-4 (1036 and 341750) at PDK 48 and 20, respectively.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740949     DOI: 10.4269/ajtmh.2003.69.6_suppl.0690005

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

Review 1.  Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? There Is Only One True Winner.

Authors:  Scott B Halstead
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

Review 2.  Latest developments and future directions in dengue vaccines.

Authors:  Usa Thisyakorn; Chule Thisyakorn
Journal:  Ther Adv Vaccines       Date:  2014-01

3.  Cell-specific adaptation of two flaviviruses following serial passage in mosquito cell culture.

Authors:  Alexander T Ciota; Amy O Lovelace; Kiet A Ngo; An N Le; Joseph G Maffei; Mary A Franke; Anne F Payne; Susan A Jones; Elizabeth B Kauffman; Laura D Kramer
Journal:  Virology       Date:  2006-09-11       Impact factor: 3.616

4.  Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission.

Authors:  Amy C Morrison; Sharon L Minnick; Claudio Rocha; Brett M Forshey; Steven T Stoddard; Arthur Getis; Dana A Focks; Kevin L Russell; James G Olson; Patrick J Blair; Douglas M Watts; Moises Sihuincha; Thomas W Scott; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2010-05-04

5.  The protein DIIIC-2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV-2.

Authors:  Lázaro Gil; Ernesto Marcos; Alienys Izquierdo; Laura Lazo; Iris Valdés; Peris Ambala; Lucy Ochola; Rikoi Hitler; Edith Suzarte; Mayling Álvarez; Prisilla Kimiti; James Ndung'u; Thomas Kariuki; María Guadalupe Guzmán; Gerardo Guillén; Lisset Hermida
Journal:  Immunol Cell Biol       Date:  2014-09-02       Impact factor: 5.126

6.  Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.

Authors:  Ching-Juh Lai; Ana P Goncalvez; Ruhe Men; Claire Wernly; Olivia Donau; Ronald E Engle; Robert H Purcell
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

7.  High-dimensional CyTOF analysis of dengue virus-infected human DCs reveals distinct viral signatures.

Authors:  Rebecca E Hamlin; Adeeb Rahman; Theodore R Pak; Kevin Maringer; Ignacio Mena; Dabeiba Bernal-Rubio; Uma Potla; Ana M Maestre; Anthony C Fredericks; El-Ad D Amir; Andrew Kasarskis; Irene Ramos; Miriam Merad; Ana Fernandez-Sesma
Journal:  JCI Insight       Date:  2017-07-06

Review 8.  Targeted mutagenesis as a rational approach to dengue virus vaccine development.

Authors:  Joseph E Blaney; Anna P Durbin; Brian R Murphy; Stephen S Whitehead
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

9.  Dengue virus activates membrane TRAIL relocalization and IFN-α production by human plasmacytoid dendritic cells in vitro and in vivo.

Authors:  Mariana Gandini; Christophe Gras; Elzinandes Leal Azeredo; Luzia Maria de Oliveira Pinto; Nikaïa Smith; Philippe Despres; Rivaldo Venâncio da Cunha; Luiz José de Souza; Claire Fernandes Kubelka; Jean-Philippe Herbeuval
Journal:  PLoS Negl Trop Dis       Date:  2013-06-06

10.  Host cell transcriptome profile during wild-type and attenuated dengue virus infection.

Authors:  October M Sessions; Ying Tan; Kenneth C Goh; Yujing Liu; Patrick Tan; Steve Rozen; Eng Eong Ooi
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.